These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 10856561)

  • 21. Clinical outcomes associated with conversion to tacrolimus-based immunosuppression in pediatric cardiac transplantation.
    Walker RE; McCrindle BW; Coles JG; West LJ
    Transplant Proc; 1998 Jun; 30(4):1116-7. PubMed ID: 9636452
    [No Abstract]   [Full Text] [Related]  

  • 22. Cyclosporine therapy in pancreas transplantation.
    Davidson I; Lu C; Melone D; Risser R
    Transplant Proc; 1996 Aug; 28(4):2134-5. PubMed ID: 8769179
    [No Abstract]   [Full Text] [Related]  

  • 23. Immunosuppression induction with rabbit antithymocyte globulin in heart transplantation patients: 6-year experience at the Sheba Medical Center.
    Lavee J; Bar-Zohar D; Har-Zahav Y; Freimark D; Casif Y; Shinfeld A; Smolinsky AK
    Transplant Proc; 2000 Jun; 32(4):737-9. PubMed ID: 10856565
    [No Abstract]   [Full Text] [Related]  

  • 24. Clinical experience with Prograf (tacrolimus, FK 506) in Chinese patients after renal transplantation.
    Yu L; Wang Y; Fu SJ; Cheng XJ
    Transplant Proc; 2000 Nov; 32(7):1709-10. PubMed ID: 11119902
    [No Abstract]   [Full Text] [Related]  

  • 25. Ten year experience in orthotopic heart transplantation: single center result.
    Aziz T; el-Gamel A; Krysiak P; Rahman A; Campbell C; Yonan N; Deiraniya A
    Transplant Proc; 1998 Aug; 30(5):1915-6. PubMed ID: 9723331
    [No Abstract]   [Full Text] [Related]  

  • 26. Improved survival after lung transplantation in patients treated with tacrolimus/mycophenolate mofetil as compared with cyclosporine/azathioprine.
    Izbicki G; Shitrit D; Aravot D; Sulkes J; Saute M; Sahar G; Kramer MR
    Transplant Proc; 2002 Dec; 34(8):3258-9. PubMed ID: 12493439
    [No Abstract]   [Full Text] [Related]  

  • 27. Conversion from regular cyclosporine to microemulsion cyclosporine following heart transplantation.
    Heroux AL; LeBlanc MH; Beaudoin D; Simard S; Coulombe DA; Gleeton O; Lemieux MD; Doyle DP
    Transplant Proc; 1996 Dec; 28(6):3145-8. PubMed ID: 8962219
    [No Abstract]   [Full Text] [Related]  

  • 28. Permanent blindness after cyclosporine neurotoxicity in a kidney-pancreas transplant recipient.
    Esterl RM; Gupta N; Garvin PJ
    Clin Neuropharmacol; 1996 Jun; 19(3):259-66. PubMed ID: 8726545
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aspects of cyclosporine A toxicity in the development of coronary artery disease in transplant recipients.
    Hennersdorf F; Wellnhofer E; Musci M; Bocksch W; Spiegelsberger S; Heins S; Hetzer R; Fleck E
    Transplant Proc; 2002 Jun; 34(4):1185-8. PubMed ID: 12072310
    [No Abstract]   [Full Text] [Related]  

  • 30. Altered disposition of pravastatin following concomitant drug therapy with cyclosporin A in transplant recipients.
    Regazzi MB; Iacona I; Campana C; Raddato V; Lesi C; Perani G; Gavazzi A; Viganò M
    Transplant Proc; 1993 Aug; 25(4):2732-4. PubMed ID: 8356729
    [No Abstract]   [Full Text] [Related]  

  • 31. Survival of heart transplant recipients with cyclosporine-induced renal insufficiency.
    van Gelder T; Balk AH; Zietse R; Hesse C; Mochtar B; Weimer W
    Transplant Proc; 1998 Jun; 30(4):1122-3. PubMed ID: 9636455
    [No Abstract]   [Full Text] [Related]  

  • 32. Evaluation of tolerability, safety, and efficacy of cyclosporine microemulsion in renal transplant recipients.
    Gracida C; Melchor JL; Miranda ME; Bartolano C
    Transplant Proc; 1996 Aug; 28(4):2171-3. PubMed ID: 8769191
    [No Abstract]   [Full Text] [Related]  

  • 33. Role of immunosuppressive therapy in neuroendocrine activation after human heart, renal, and liver transplantation.
    Piquard F; Geny B; Elero B; Canguilhem B; Mettauer B; Epailly E; Chakfe N; Charpentier A; Wolf P; Kretz JG; Eisenmann B; Koehl C; Haberey P
    Transplant Proc; 1998 Aug; 30(5):2124-6. PubMed ID: 9723414
    [No Abstract]   [Full Text] [Related]  

  • 34. Conversion to tacrolimus in case-problem kidney transplant recipients under cyclosporine-based immunosuppression.
    Martins L; Henriques AC; Dias L; Sarmento AM; Pereira MC; Guimaräes S
    Transplant Proc; 2000 Dec; 32(8):2636-8. PubMed ID: 11134735
    [No Abstract]   [Full Text] [Related]  

  • 35. The effect of cyclosporin A on the level of big endothelin in patients one year after orthotopic heart transplantation.
    Kocík M; Málek I; Glagolicová A; Pirk J
    Transpl Int; 2004 Feb; 17(2):65-70. PubMed ID: 14634722
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical safety and tolerability of microemulsion cyclosporine in stable renal transplant patients.
    Gracida C; Melchor JL
    Transplant Proc; 1996 Dec; 28(6):3379. PubMed ID: 8962318
    [No Abstract]   [Full Text] [Related]  

  • 37. One and a half years of experience with mycophenolate mofetil (Cellcept) in cardiac transplantation: a prospective, randomized study.
    Seebacher G; Weigel G; Griesmacher A; Mallinger R; Zuckermann A; Grimm M; Laufer G
    Transplant Proc; 1999 Dec; 31(8):3291-3. PubMed ID: 10616480
    [No Abstract]   [Full Text] [Related]  

  • 38. Benefits of mycophenolate mofetil in cardiac transplant recipients with cyclosporine-induced nephropathy.
    Sánchez V; Delgado JF; Blasco T; Dalmau R; Morales JM; Escribano P; Tello R; Hernández J; Velázquez T; Sotelo T; Gómez-Sánchez MA; Sáenz de la Calzada C
    Transplant Proc; 1999 Sep; 31(6):2515-6. PubMed ID: 10500695
    [No Abstract]   [Full Text] [Related]  

  • 39. Low-dose oral prednisone in the treatment of acute cardiac allograft rejection.
    Delgado JF; Pombo M; Dalmau R; Gómez-Sánchez MA; Escribano P; Lázaro M; Velázquez MT; Sánchez V; Sáenz de la Calzada C; Rufilanchas JJ
    Transplant Proc; 2002 Feb; 34(1):117. PubMed ID: 11959215
    [No Abstract]   [Full Text] [Related]  

  • 40. Medium-term outcome of tacrolimus immunosuppression following rejection or graft dysfunction in heart transplant patients.
    Marcus N; Khaghani A; Burke M; Yacoub M; Banner N
    Transplant Proc; 1998 Jun; 30(4):1134-5. PubMed ID: 9636460
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.